SEARCH RESULTS FOR:

United States
Pharma & Life Sciences

Rajiv Anand

FOUNDER AND CEO, QUARTIC.AI
AI in the Life Sciences 2020
Quartic AI explains how artificial intelligence and machine learning should be applied in life sciences.
Mining
Peru

Sandro Tavonatti

CEO, INGENIERÍA Y CONSTRUCCIÓN SIGDO KOPPERS
Ingeniería y Construcción Sigdo Koppers in Peru comments on its ongoing projects in the mining sector in Peru.
Mining
DRC
MACIG

Louis Watum

PRESIDENT OF THE CHAMBER OF MINES, DRC
The Chamber of Mines of the DRC explains the conditions relating to the mining industry there.
Mining
Peru

Jorge León Benavides

PRESIDENT, CHAMBER OF COMMERCE CANADA PERU (CCCP)
Jorge León Benavides explains how the CCCP promotes business and investment in Peru.
Mining
Canada

Mark Selby

CHAIR & CEO, CANADA NICKEL COMPANY
Canada Nickel Company is developing a large nickel project at Crawford, north of Timmins.
Mining
Peru

Ricardo Ishida

GENERAL MANAGER – PERÚ, LIEBHERR
Liebherr began operations in Peru in 2019 and describes how it plans to penetrate the market with its trucks and shovels.
Mining
Canada

Doug Ramshaw

PRESIDENT, MINERA ALAMOS
Minera Alamos has put together some exciting gold projects in Mexico and explains their development plans.
Mining
Canada

Peter C. Dougherty

PRESIDENT & CEO, ARGONAUT GOLD
Argonaut Gold updates on progress at its gold projects throughout North America.
Mining
South Africa
Botswana
Zambia
DRC
Tanzania
Cote d’Ivoire
Ghana
MACIG

Stephen Smithyman

CEO, KANU EQUIPMENT
Kanu Equipment comments on the challenges and opportunities in Africa for a mining and construction dealership.
Mexico
Petrochemicals & Chemicals

Marco Salcedo

DIRECTOR, AMVAC MÉXICO
AMVAC Mexico explains how it is growing through developing its portfolio with a particular emphasis on biological products.

MACIG

SPANISH

SUBSCRIBE TO OUR NEWSLETTER

RECENT PUBLICATIONS

United States Life Sciences 2025 - Digital Interactive

Resilience amid uncertainty. These words encapsulate the US life sciences sector as it navigates 2025. While the industry has largely rebounded from the recent biotech bear market, with clinical trial starts and funding showing signs of rebound, headwinds remain.
MORE PREVIOUSLY PUBLISHED

PARTNER EVENTS

SEE ALL